Ever since Prozac started making headlines back in the 1990s, I’ve been dubious about the “brain chemistry” approach to treating mood disorders with SSRIs, because of a common-sense skepticism toward the claims of scientific “experts.” Is it really a smart idea to be loading people up on complex chemicals with all kinds of potential long-term effects? I mean, how many people who start on anti-depressants in their teens or 20s ever actually get well?
That is to say, shouldn’t the goal of psychiatric treatment be to get patients to the point where they don’t need treatment any more?
On the other hand, the goal of pharmaceutical manufacturers is to keep the cash coming in, which requires that patients not get well. There will never, for instance, be a cure for type 2 diabetes, because there’s so much money to be made by drugging the sufferers indefinitely. Besides, actual cures tend to be extraordinarily expensive; the Death Panels™ are loath to spend that sort of money on people, unless campaign contributions are at stake.
And yet I can’t remember anyone ever saying, “Yes, I was diagnosed with chronic depression, but I took these pills for six months and it went away, so now I don’t need the pills anymore and I’m as cheerful as a songbird all the time.” But I digress …
No songbird, I; however, during the last quarter-century I have been prescribed two industrial-strength anti-depressants — neither, admittedly, SSRIs — and after all that, mood regulation is now left to a single benzo at a low dosage.
Still, I’m not claiming to be “cured,” only to be somewhat better able to cope.